A drug for treating schizophrenia which comprises as the active ingredient a compound having an mGluR1 antagonism or a pharmaceutically acceptable salt thereof. More specifically speaking, a drug for treating schizophrenia which comprises as the active ingredient a compound having an mGluR1 antagonism and being represented by the following general formula [1] or a pharmaceutically acceptable salt thereof: [1]
展开▼
